NCT00675090 - Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 21, 2008

Primary Completion Date

June 16, 2009

Study Completion Date

June 16, 2009

Conditions

Alzheimer's Disease

Interventions

DRUG

GSK239512

GSK239512 oral tablets once a day

DRUG

Placebo

Placebo tablets to match once a day

Trial Locations (8)

GSK Investigational Site, Randwick

GSK Investigational Site, Heidelberg Heights

GSK Investigational Site, Prague

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Cambridgeshire

GSK Investigational Site, London

GSK Investigational Site, Southall